Novo Nordisk A/S, No. 25-cv-00713, alleges that the company and its key executives committed securities violations during the Phase 3 trial of CagriSema, known as REDEFINE-1. Investors who ...

San Francisco is becoming rattier — literally. According to a new study, San Francisco’s rat population has grown faster than many of its peer cities in recent years. The research ...

Enter the pack rats. As the name suggests, these rodents are the original hoarders. They have bigger ears, furrier tails, and a greater love of shiny objects than others of their kind. Much of ...

New York is facing its rat problem head-on. New York City is known for its towering skyscrapers and bustling streets, but lurking beneath the glitz and glamour of the city that never sleeps are 3 ...

Scientists are training the first generation of rats in Tanzania to detect illegal wildlife trafficked products. Their research shows that African giant pouched rats can locate concealed wildlife ...

LONDON/COPENHAGEN (Reuters) -Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data published in December that disappointed ...

LONDON/COPENHAGEN (Reuters) -Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data published in December that disappointed investors ...

LONDON/SAN FRANCISCO (Reuters) - Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema amid a lack of clarity over trial results ...